rs180177327
Variant summary
Our verdict is Pathogenic. The variant received 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The NM_017890.5(VPS13B):c.3348_3349delCT(p.Cys1117PhefsTer8) variant causes a frameshift change. The variant allele was found at a frequency of 0.000111 in 1,613,806 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Pathogenic (★★). Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
NM_017890.5 frameshift
Scores
Clinical Significance
Conservation
Publications
- Cohen syndromeInheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, Myriad Women’s Health, Labcorp Genetics (formerly Invitae), G2P, Genomics England PanelApp, Laboratory for Molecular Medicine, ClinGen
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 18 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| VPS13B | NM_017890.5 | c.3348_3349delCT | p.Cys1117PhefsTer8 | frameshift_variant | Exon 23 of 62 | ENST00000358544.7 | NP_060360.3 | |
| VPS13B | NM_152564.5 | c.3348_3349delCT | p.Cys1117PhefsTer8 | frameshift_variant | Exon 23 of 62 | ENST00000357162.7 | NP_689777.3 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| VPS13B | ENST00000358544.7 | c.3348_3349delCT | p.Cys1117PhefsTer8 | frameshift_variant | Exon 23 of 62 | 1 | NM_017890.5 | ENSP00000351346.2 | ||
| VPS13B | ENST00000357162.7 | c.3348_3349delCT | p.Cys1117PhefsTer8 | frameshift_variant | Exon 23 of 62 | 1 | NM_152564.5 | ENSP00000349685.2 |
Frequencies
GnomAD3 genomes AF: 0.000256 AC: 39AN: 152098Hom.: 0 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.000227 AC: 57AN: 251260 AF XY: 0.000184 show subpopulations
GnomAD4 exome AF: 0.0000958 AC: 140AN: 1461708Hom.: 0 AF XY: 0.0000839 AC XY: 61AN XY: 727166 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.000256 AC: 39AN: 152098Hom.: 0 Cov.: 32 AF XY: 0.000390 AC XY: 29AN XY: 74298 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
Cohen syndrome Pathogenic:6Other:1
NM_017890.4(VPS13B):c.3348_3349delCT(C1117Ffs*8) is classified as pathogenic in the context of Cohen syndrome. Sources cited for classification include the following: PMID 12730828 and 15141358. Classification of NM_017890.4(VPS13B):c.3348_3349delCT(C1117Ffs*8) is based on the following criteria: The variant causes a premature termination codon that is expected to be targeted by nonsense-mediated mRNA decay and is reported in individuals with the relevant phenotype. Please note: this variant was assessed in the context of healthy population screening. -
- -
- -
This variant is present in population databases (rs774683328, gnomAD 0.3%). This premature translational stop signal has been observed in individual(s) with Cohen syndrome (PMID: 12730828, 15141358). ClinVar contains an entry for this variant (Variation ID: 2818). For these reasons, this variant has been classified as Pathogenic. This sequence change creates a premature translational stop signal (p.Cys1117Phefs*8) in the VPS13B gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in VPS13B are known to be pathogenic (PMID: 15141358, 16648375, 20461111). -
- -
- -
Variant summary: VPS13B c.3348_3349delCT (p.Cys1117PhefsX8) results in a premature termination codon, predicted to cause a truncation of the encoded protein or absence of the protein due to nonsense mediated decay, which are commonly known mechanisms for disease. Truncations downstream of this position have been classified as pathogenic by our laboratory. The variant allele was found at a frequency of 0.00023 in 251260 control chromosomes. c.3348_3349delCT has been reported in the literature as a recurrent Finnish founder variant in multiple individuals affected with Cohen Syndrome (Kolehmainen_2003) and has been subsequently cited by others in the field (example, Enomoto_2020, Kondo_2005, Lou_2020, Nasser_2020). These data indicate that the variant is very likely to be associated with disease. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. Three clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar after 2014 without evidence for independent evaluation. All laboratories classified the variant as pathogenic. Based on the evidence outlined above, the variant was classified as pathogenic. -
not provided Pathogenic:1Other:1
- -
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at